Literature DB >> 17669593

Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions.

Jihwan Song1, Soon-Tae Lee, Wonsuk Kang, Jung-Eun Park, Kon Chu, Song-ee Lee, Taesun Hwang, Hyungmin Chung, Manho Kim.   

Abstract

To test the efficacy of human embryonic stem cell (hESC)-derived neural precursors in an experimental model of Huntington's disease (HD), we differentiated hESC into nestin-positive neural precursors by co-culturing with PA6 stromal cells, and subsequently transplanted them into the striatum of quinolinic acid (QA)-induced HD model. The transplanted animals exhibited a behavioral recovery in the apomorphine-induced rotation test for 3 weeks after transplantation. The transplanted hESC-derived neural precursors were found in both cortex and striatum. They also exhibited some evidence of neuronal differentiation. At the time of examination, no tumor was detected. These results strongly suggest that hESC-derived neural precursors can lead to a behavioral recovery, as well as neuronal differentiation, in the pre-clinical model of HD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669593     DOI: 10.1016/j.neulet.2007.05.066

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  30 in total

1.  Behavioural profile of Wistar rats with unilateral striatal lesion by quinolinic acid (animal model of Huntington disease) post-injection of apomorphine and exposure to static magnetic field.

Authors:  Carolina Giorgetto; Elaine Cristina Mazzei Silva; Takae Tamy Kitabatake; Guilherme Bertolino; João Eduardo de Araujo
Journal:  Exp Brain Res       Date:  2015-02-11       Impact factor: 1.972

2.  A mechanism-based complementary screening approach for the amelioration and reversal of neurobehavioral teratogenicity.

Authors:  Joseph Yanai; Yael Brick-Turin; Sharon Dotan; Rachel Langford; Adi Pinkas; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2009-02-13       Impact factor: 3.763

3.  Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.

Authors:  Kyle D Fink; Andrew T Crane; Xavier Lévêque; Dylan J Dues; Lucas D Huffman; Allison C Moore; Darren T Story; Rachel E Dejonge; Aaron Antcliff; Phillip A Starski; Ming Lu; Laurent Lescaudron; Julien Rossignol; Gary L Dunbar
Journal:  Stem Cells Transl Med       Date:  2014-03-21       Impact factor: 6.940

Review 4.  Concise Review: Human-Animal Neurological Chimeras: Humanized Animals or Human Cells in an Animal?

Authors:  Andrew T Crane; Joseph P Voth; Francis X Shen; Walter C Low
Journal:  Stem Cells       Date:  2019-01-28       Impact factor: 6.277

Review 5.  Stem Cells Transplantation and Huntington's Disease.

Authors:  Wooseok Im; Soon-Tae Lee; Kon Chu; Manho Kim; Jae-Kyu Roh
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

Review 6.  Induced pluripotent stem cells and neurodegenerative diseases.

Authors:  Chao Chen; Shi-Fu Xiao
Journal:  Neurosci Bull       Date:  2011-04       Impact factor: 5.203

Review 7.  Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Authors:  Sandra M Holley; Talia Kamdjou; Jack C Reidling; Brian Fury; Dane Coleal-Bergum; Gerhard Bauer; Leslie M Thompson; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-03-06       Impact factor: 5.243

8.  Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism.

Authors:  Cindy Casteels; Emili Martinez; Guy Bormans; Lluïsa Camon; Núria de Vera; Veerle Baekelandt; Anna M Planas; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-03       Impact factor: 9.236

9.  Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.

Authors:  Camille Nicoleau; Pedro Viegas; Marc Peschanski; Anselme L Perrier
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 10.  Modeling Huntington's disease with induced pluripotent stem cells.

Authors:  Julia A Kaye; Steven Finkbeiner
Journal:  Mol Cell Neurosci       Date:  2013-02-28       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.